Lighthouse Pharmaceuticals, Inc. · CIK 2133359
Lighthouse Pharmaceuticals, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
May 7, 2026
through May 7, 2026
through May 7, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $15,206,800
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $15,206,800
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (1)
-
0002133359-26-000001D · May 7, 2026 · OtherOffering: $15,206,800Sold: $15,206,800